tiprankstipranks
Predictive Oncology Announces Chief Business Officer Transition
Company Announcements

Predictive Oncology Announces Chief Business Officer Transition

Predictive Oncology Inc (POAI) has released an update to notify the public and investors about its officers.

Predictive Oncology Inc. will see the departure of its Chief Business Officer, Dr. Pamela Bush, by February 15, 2024. The company is actively seeking a replacement as part of its ongoing strategy for corporate development, signaling a commitment to maintaining its momentum in the business landscape.

For further insights into POAI corporate activity, check out TipRanks’ Insiders Trading Activity page.

For a comprehensive understanding of the announcement, you can read the full document here.

Related Articles
GlobeNewswirePredictive Oncology Develops Novel Stem Cell Expression System for the Production of Functional and Stable G-Protein Coupled Receptors (GPCRs)
TheFlyPredictive Oncology develops technology designed to express GPCRs
TheFlyPredictive Oncology launches novel 3D cell technology
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!